Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 2/20 | 0.42 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.40 |
| ▸ | FABP7 | O15540 | 1/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29400520 | 1.00 | KMT2A (0.51) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL3060297 | 1.00 | KMT2A (0.51) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL29995975 | 0.95 | KMT2A (0.48) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL30895521 | 0.95 | KMT2A (0.48) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL3087950 | 0.88 | KMT2A (0.58) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL29470973 | 0.84 | KMT2A (0.57) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL12391727 | 0.84 | KMT2A (0.57) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL7855942 | 0.84 | KMT2A (0.69) | KMT2AEPHX2CASP3 | |
| SCHEMBL17015150 | 0.84 | KMT2A (0.57) | KMT2AEPHX2OPRD1CASP3FABP5 | |
| SCHEMBL30174112 | 0.83 | KMT2A (0.59) | KMT2AEPHX2OPRD1CASP3FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025237891-A1 | QUINOLINE-2-CARBOXAMIDE DERIVATIVES AS RAD51 INHIBITORS FOR THE TREATMENT OF CANCER | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2025-11-20 | — | — | WO | disclosed |